About Keratinocyte differentiation factor 1
Keratinocyte differentiation factor 1 (KDF1) is a protein
from Homo sapiens identified by UniProt accession
Q8NAX2, 398 residues long.
MolForge cross-references it against 0 known binders and
72 disease associations.
Target properties
| Protein name | Keratinocyte differentiation factor 1 |
| UniProt accession | Q8NAX2 |
| Gene | KDF1 |
| Organism | Homo sapiens |
| Length | 398 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (72)
Diseases linked to this target (Open Targets).
- autosomal dominant hypohidrotic ectodermal dysplasia · score 0.45
- tooth agenesis · score 0.29
- sex hormone-binding globulin measurement · score 0.26
- myeloid white cell count · score 0.25
- vitamin D measurement · score 0.20
- testosterone measurement · score 0.19
- genetic disorder · score 0.19
- reticulocyte count · score 0.17
- heel bone mineral density · score 0.16
- neutrophil count · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NAX2-F1 | alphafold | PREDICTED | 58.86 | — |
Amino-acid sequence (398 residues)
MPRPGHPRPA SGPPRLGPWE RPTELCLETY DKPPQPPPSR RTRRPDPKDP GHHGPESITF ISGSAEPALE SPTCCLLWRP WVWEWCRAAF CFRRCRDCLQ RCGACVRGCS PCLSTEDSTE GTAEANWAKE HNGVPPSPDR APPSRRDGQR LKSTMGSSFS YPDVKLKGIP VYPYPRATSP APDADSCCKE PLADPPPMRH SLPSTFASSP RGSEEYYSFH ESDLDLPEMG SGSMSSREID VLIFKKLTEL FSVHQIDELA KCTSDTVFLE KTSKISDLIS SITQDYHLDE QDAEGRLVRG IIRISTRKSR ARPQTSEGRS TRAAAPTAAA PDSGHETMVG SGLSQDELTV QISQETTADA IARKLRPYGA PGYPASHDSS FQGTDTDSSG APLLQVYC
Explore Keratinocyte differentiation factor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets